A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see how safe and effective Lacosamide (LCM) is when taken by
mouth, twice a day for up to 18 weeks to prevent migraines.